Note: Ingredients listed on restricted chemical lists
EC/CAS
203-905-0/111-76-2
Name of the chemical
Ethylene glycol monobutyl ether (EGBE)
Concentration
5 - 10
General Information
Version
5.1
Revision date
2024-08-26
Product name
Citrus Tar and Glue Remover
supplier name
for the SDS
Emergency telephone
+44(0)1323 287980, 0344 892 0111
Icons in SDS
Company Information
company name
ValetPRO Limited
e-mail address of the competent person responsible for the Safety Data Sheet
sds@wrenchemservices.com, sds@valetpro.global
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H304, H315, H317, H319
Hazard statements
Code
Statements
H304
May be fatal if swallowed and enters airways
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. May be fatal if swallowed and enters airways.
2.2 Label elements
Labelling
Hazard pictograms
GHS07 GHS08
Signal word
Danger
Contains
Distillates (petroleum), hydrotreated light; 2-Ethylhexyl-S-Lactate
Hazard statements
H304 - May be fatal if swallowed and enters airways. H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation.
Precautionary statements
P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P280 - Wear eye protection, protective gloves. P301+P310+P331 - IF SWALLOWED: Immediately call a doctor. Do NOT induce vomiting. P405 - Store locked up. P501 - Dispose of contents and container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
